DOI QR코드

DOI QR Code

Phenotypic Differences of Gastric Cancer according to the Helicobacter pylori Infection in Kor ean Patients

  • Park, Dong-Wook (Department of Surgery, Korea Cancer Center Hospital, Korea Institute of Radiological & Medical Sciences (KIRAMS)) ;
  • Lee, Kyu-Jae (Department of Surgery, Korea Cancer Center Hospital, Korea Institute of Radiological & Medical Sciences (KIRAMS)) ;
  • Jin, Sung-Ho (Department of Surgery, Korea Cancer Center Hospital, Korea Institute of Radiological & Medical Sciences (KIRAMS)) ;
  • Lee, Jae-Hwan (Department of Surgery, Korea Cancer Center Hospital, Korea Institute of Radiological & Medical Sciences (KIRAMS)) ;
  • Min, Jae-Seok (Department of Surgery, Dongnam Institute of Radiological & Medical Sciences) ;
  • Park, Sun-Hoo (Department of Pathology, KIRAMS) ;
  • Yu, Hang-Jong (Department of Surgery, Korea Cancer Center Hospital, Korea Institute of Radiological & Medical Sciences (KIRAMS)) ;
  • Bang, Ho-Yoon (Department of Surgery, Konkuk University Hospital) ;
  • Lee, Jong-Inn (Department of Surgery, Korea Cancer Center Hospital, Korea Institute of Radiological & Medical Sciences (KIRAMS))
  • 투고 : 2010.09.29
  • 심사 : 2010.11.04
  • 발행 : 2010.12.30

초록

Purpose: Infection with Helicobacter pylori is an important risk factor for gastric cancer in humans. We compared the clinicopathologic features of gastric cancer patients based on H. pylori infection. Materials and Methods: We prospectively studied 155 patients who had gastric cancer and underwent gastrectomies in 1 hospital in Korea. We examined H. pylori infections using the rapid urease test (RUT) with gastrectomy specimens and collected clinical and pathologic data. Results: The number of H. pylori infections based on the RUT was 137 (88%). The H. pylori-negative group was significantly associated with AGC and tumor histology. H. pylori infection was significantly correlated with type I/IIa in EGC and type III/IV/V in AGC. AGC was significantly correlated with larger tumor size, lymphatic invasion, perineural invasion, and H. pylori infection based on univariate and multivariate analyses. Conclusions: We report the prevalence of H. pylori based on the RUT in gastric cancer patients. H. pylori infection influences the tumor histology, progression, and growth type of gastric cancer.

키워드

참고문헌

  1. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983;1:1273-1275.
  2. Fox JG, Correa P, Taylor NS, Zavala D, Fontham E, Janney F, et al. Campylobacter pylori-associated gastritis and immune response in a population at increased risk of gastric carcinoma. Am J Gastroenterol 1989;84:775-781.
  3. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991;325:1127-1131. https://doi.org/10.1056/NEJM199110173251603
  4. Schistosomes, liver flukes and Helicobacter pylori . IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. IARC Monogr Eval Carcinog Risks Hum 1994;61:1-241
  5. Huang JQ, Sridhar S, Chen Y, Hunt RH. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 1998;114:1169-1179. https://doi.org/10.1016/S0016-5085(98)70422-6
  6. Hatakeyama M. Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nat Rev Cancer 2004;4:688-694. https://doi.org/10.1038/nrc1433
  7. Yamaoka Y, Kodama T, Gutierrez O, Kim JG, Kashima K, Graham DY. Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four diff erent countries. J Clin Microbiol 1999;37:2274-2279.
  8. Houghton J, Wang TC. Helicobacter pylori and gastric cancer: a new paradigm for inflammation-associated epithelial cancers. Gastroenterology 2005;128:1567-1578. https://doi.org/10.1053/j.gastro.2005.03.037
  9. Stoicov C, Saff ari R, Cai X, Hasyagar C, Houghton J. Molecular biology of gastric cancer: Helicobacter infection and gastric adenocarcinoma: bacterial and host factors responsible for altered growth signaling. Gene 2004;341:1-17. https://doi.org/10.1016/j.gene.2004.07.023
  10. Kim SI, Jin SH, Lee JH, Min JS, Bang HY, Lee JY. An alternative method for a rapid urease test using back-table gastric mucosal biopsies from gastrectomy specimen for making the diagnosis of Helicobacter pylori infection on patients with gastric cancer. J Korean Gastric Cancer Assoc 2009;9:172-176. https://doi.org/10.5230/jkgca.2009.9.4.172
  11. AJCC, eds. AJCC Cancer Staging Manual. 6th ed. New York: Springer, 2002.
  12. AJCC, eds. AJCC Cancer Staging Manual. 7th ed. New York: Springer, 2009.
  13. Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori : a combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001;49:347-353. https://doi.org/10.1136/gut.49.3.347
  14. Watanabe Y, Kurata JH, Mizuno S, Mukai M, Inokuchi H, Miki K, et al. Helicobacter pylori infection and gastric cancer. A nested case-control study in a rural area of Japan. Dig Dis Sci 1997;42:1383-1387. https://doi.org/10.1023/A:1018833819860
  15. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784-789. https://doi.org/10.1056/NEJMoa001999
  16. Shin A, Shin HR, Kang D, Park SK, Kim CS, Yoo KY. A nested case-control study of the association of Helicobacter pylori infection with gastric adenocarcinoma in Korea. Br J Cancer 2005;92:1273-127 https://doi.org/10.1038/sj.bjc.6602467
  17. Crabtree JE, Wyatt JI, Trejdosiewicz LK, Peichl P, Nichols PH, Ramsay N, et al. Interleukin-8 expression in Helicobacter pylori infected, normal, and neoplastic gastroduodenal mucosa. J Clin Pathol 1994;47:61-66. https://doi.org/10.1136/jcp.47.1.61
  18. Negrini R, Savio A, Appelmelk BJ. Autoantibodies to gastric mucosa in Helicobacter pylori infection. Helicobacter 1997;2 (Suppl 1):S13-S16.
  19. Suzuki H, Hibi T. Oxidative stress in Helicobacter pylori-associated gastroduodenal disease. J Clin Biochem Nutr 2006;39:56-63. https://doi.org/10.3164/jcbn.39.56
  20. Parsonnet J, Vandersteen D, Goates J, Sibley RK, Pritikin J, Chang Y. Helicobacter pylori infection in intestinal- and diffuse-type gastric adenocarcinomas. J Natl Cancer Inst 1991;83:640-643. https://doi.org/10.1093/jnci/83.9.640
  21. Kim DY, Park YK, Joo JK, Ryu SY, Kim YJ, Kim SK, et al. Clinicopathological characteristics of signet ring cell carcinoma of the stomach. ANZ J Surg 2004;74:1060-1064. https://doi.org/10.1111/j.1445-1433.2004.03268.x
  22. Tatsuta M, Iishi H, Okuda S, Taniguchi H, Yokota Y. Th e association of Helicobacter pylori with diff erentiated-type early gastric cancer. Cancer 1993;72:1841-1845. https://doi.org/10.1002/1097-0142(19930915)72:6<1841::AID-CNCR2820720608>3.0.CO;2-I
  23. Lee WJ, Lin JT, Lee WC, Shun CT, Hong RL, Cheng AL, et al. Clinicopathologic characteristics of Helicobacter pyloric seropositive gastric adenocarcinomas. J Clin Gastroenterol 1995;21:203-207. https://doi.org/10.1097/00004836-199510000-00007
  24. Meimarakis G, Winter H, Assmann I, Kopp R, Lehn N, Kist M, et al. Helicobacter pylori as a prognostic indicator after curative resection of gastric carcinoma: a prospective study. Lancet Oncol 2006;7:211-222. https://doi.org/10.1016/S1470-2045(06)70586-1

피인용 문헌

  1. Usefulness of a Helicobacter pylori stool antigen test for diagnosing H. pylori infected C57BL/6 mice vol.29, pp.1, 2010, https://doi.org/10.5625/lar.2013.29.1.27
  2. Usefulness of a Helicobacter pylori stool antigen test for diagnosing H. pylori infected C57BL/6 mice vol.29, pp.1, 2010, https://doi.org/10.5625/lar.2013.29.1.27
  3. Molecular Diagnosis for Personalized Target Therapy in Gastric Cancer vol.13, pp.3, 2010, https://doi.org/10.5230/jgc.2013.13.3.129
  4. Characteristics of gastric cancer according to Helicobacter pylori infection status vol.29, pp.9, 2014, https://doi.org/10.1111/jgh.12605